3-acetyl-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]-7-(methylamino)indolizine-1-carboxamide
C23H22FN5O3 — CID 154631632
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-acetyl-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]-7-(methylamino)indolizine-1-carboxamide
3-acetyl-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]-7-(methylamino)indolizine-1-carboxamide (PubChem CID 154631632) has the molecular formula C23H22FN5O3 and a molecular weight of 435.46 g/mol. Its IUPAC name is 3-acetyl-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]-7-(methylamino)indolizine-1-carboxamide.
Molecular Properties
| Compound Name | 3-acetyl-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]-7-(methylamino)indolizine-1-carboxamide |
|---|---|
| PubChem CID | 154631632 |
| Molecular Formula | C23H22FN5O3 |
| Molecular Weight | 435.46 g/mol |
| Exact Mass | 435.17 |
| IUPAC Name | 3-acetyl-N-[2-fluoro-5-(hydroxymethyl)-3-(1-methylpyrazol-4-yl)phenyl]-7-(methylamino)indolizine-1-carboxamide |
| SMILES | CNc1ccn2c(C(C)=O)cc(C(=O)Nc3cc(CO)cc(-c4cnn(C)c4)c3F)c2c1 |
| InChI | InChI=1S/C23H22FN5O3/c1-13(31)20-9-18(21-8-16(25-2)4-5-29(20)21)23(32)27-19-7-14(12-30)6-17(22(19)24)15-10-26-28(3)11-15/h4-11,25,30H,12H2,1-3H3,(H,27,32) |
| InChIKey | GNVGZNTWMDXJQD-UHFFFAOYSA-N |
| XLogP | 3.47 |
| TPSA | 100.66 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.46 |
| LogP ≤ 5 | 3.47 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154631632 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.